nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—endothelium—type 2 diabetes mellitus	0.0314	0.234	CbGeAlD
Plerixafor—CXCR4—islet of Langerhans—type 2 diabetes mellitus	0.0179	0.133	CbGeAlD
Plerixafor—CXCR4—retina—type 2 diabetes mellitus	0.0153	0.114	CbGeAlD
Plerixafor—CXCR4—cardiovascular system—type 2 diabetes mellitus	0.0129	0.0962	CbGeAlD
Plerixafor—CXCR4—kidney—type 2 diabetes mellitus	0.0127	0.0941	CbGeAlD
Plerixafor—CXCR4—pancreas—type 2 diabetes mellitus	0.0126	0.0935	CbGeAlD
Plerixafor—CXCR4—cortex of kidney—type 2 diabetes mellitus	0.0123	0.0916	CbGeAlD
Plerixafor—CXCR4—adipose tissue—type 2 diabetes mellitus	0.0114	0.0848	CbGeAlD
Plerixafor—CXCR4—liver—type 2 diabetes mellitus	0.008	0.0595	CbGeAlD
Plerixafor—CXCR4—Peptide ligand-binding receptors—EDN1—type 2 diabetes mellitus	0.00116	0.0036	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—EDNRB—type 2 diabetes mellitus	0.00114	0.00355	CbGpPWpGaD
Plerixafor—CXCR4—Disease—VPS26A—type 2 diabetes mellitus	0.00113	0.00351	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—HTR2C—type 2 diabetes mellitus	0.00111	0.00345	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—MMP9—type 2 diabetes mellitus	0.00109	0.00338	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	0.00109	0.00337	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—EDNRA—type 2 diabetes mellitus	0.00108	0.00335	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	0.00106	0.00329	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	0.00106	0.00328	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—ADRA2A—type 2 diabetes mellitus	0.00106	0.00328	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—GHRL—type 2 diabetes mellitus	0.00105	0.00327	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—GNB3—type 2 diabetes mellitus	0.00104	0.00324	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	0.00104	0.00323	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCR5—type 2 diabetes mellitus	0.00104	0.00322	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—C3—type 2 diabetes mellitus	0.00102	0.00315	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	0.00101	0.00313	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—SRC—type 2 diabetes mellitus	0.00101	0.00312	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—AGT—type 2 diabetes mellitus	0.000965	0.00299	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—IAPP—type 2 diabetes mellitus	0.000938	0.00291	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—CCR5—type 2 diabetes mellitus	0.000937	0.00291	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—ADCY5—type 2 diabetes mellitus	0.000931	0.00289	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	0.000929	0.00288	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	0.000929	0.00288	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GCGR—type 2 diabetes mellitus	0.000916	0.00284	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	0.00091	0.00282	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCR5—type 2 diabetes mellitus	0.000876	0.00272	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	0.000872	0.0027	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.000867	0.00269	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—C3—type 2 diabetes mellitus	0.000856	0.00265	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	0.000849	0.00263	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	0.000846	0.00262	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GIPR—type 2 diabetes mellitus	0.000843	0.00261	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GRK5—type 2 diabetes mellitus	0.000843	0.00261	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SLC5A4—type 2 diabetes mellitus	0.000826	0.00256	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	0.000823	0.00255	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	0.000819	0.00254	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GIP—type 2 diabetes mellitus	0.000817	0.00253	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—AGT—type 2 diabetes mellitus	0.000814	0.00252	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	0.000813	0.00252	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	0.000806	0.0025	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—GHRL—type 2 diabetes mellitus	0.000802	0.00249	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PPP1R3C—type 2 diabetes mellitus	0.000798	0.00247	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ENPP1—type 2 diabetes mellitus	0.000798	0.00247	CbGpPWpGaD
Plerixafor—CXCR4—Disease—G6PC—type 2 diabetes mellitus	0.000798	0.00247	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL2—type 2 diabetes mellitus	0.000794	0.00246	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.000793	0.00246	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CALCA—type 2 diabetes mellitus	0.000793	0.00246	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	0.000779	0.00242	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—MC4R—type 2 diabetes mellitus	0.000771	0.00239	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	0.000758	0.00235	CbGpPWpGaD
Plerixafor—Vomiting—Glipizide—type 2 diabetes mellitus	0.000749	0.00138	CcSEcCtD
Plerixafor—Syncope—Metformin—type 2 diabetes mellitus	0.000748	0.00138	CcSEcCtD
Plerixafor—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000748	0.00138	CcSEcCtD
Plerixafor—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000747	0.00138	CcSEcCtD
Plerixafor—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000746	0.00137	CcSEcCtD
Plerixafor—Rash—Glipizide—type 2 diabetes mellitus	0.000742	0.00137	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—GIP—type 2 diabetes mellitus	0.000742	0.0023	CbGpPWpGaD
Plerixafor—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000742	0.00137	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000741	0.00137	CcSEcCtD
Plerixafor—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000741	0.00136	CcSEcCtD
Plerixafor—Erythema—Losartan—type 2 diabetes mellitus	0.000741	0.00136	CcSEcCtD
Plerixafor—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000739	0.00136	CcSEcCtD
Plerixafor—Headache—Glipizide—type 2 diabetes mellitus	0.000738	0.00136	CcSEcCtD
Plerixafor—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000736	0.00136	CcSEcCtD
Plerixafor—Shock—Valsartan—type 2 diabetes mellitus	0.000735	0.00135	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.000734	0.00228	CbGpPWpGaD
Plerixafor—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000733	0.00135	CcSEcCtD
Plerixafor—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000733	0.00135	CcSEcCtD
Plerixafor—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000731	0.00135	CcSEcCtD
Plerixafor—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.00073	0.00135	CcSEcCtD
Plerixafor—Flatulence—Losartan—type 2 diabetes mellitus	0.00073	0.00134	CcSEcCtD
Plerixafor—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000727	0.00134	CcSEcCtD
Plerixafor—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000726	0.00134	CcSEcCtD
Plerixafor—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000725	0.00134	CcSEcCtD
Plerixafor—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000724	0.00133	CcSEcCtD
Plerixafor—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000724	0.00133	CcSEcCtD
Plerixafor—Urticaria—Glyburide—type 2 diabetes mellitus	0.00072	0.00133	CcSEcCtD
Plerixafor—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000717	0.00132	CcSEcCtD
Plerixafor—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000717	0.00132	CcSEcCtD
Plerixafor—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000716	0.00132	CcSEcCtD
Plerixafor—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000716	0.00132	CcSEcCtD
Plerixafor—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000714	0.00132	CcSEcCtD
Plerixafor—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000711	0.00131	CcSEcCtD
Plerixafor—Malaise—Irbesartan—type 2 diabetes mellitus	0.00071	0.00131	CcSEcCtD
Plerixafor—Headache—Pioglitazone—type 2 diabetes mellitus	0.000707	0.0013	CcSEcCtD
Plerixafor—Syncope—Irbesartan—type 2 diabetes mellitus	0.000706	0.0013	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000705	0.0013	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000702	0.00129	CcSEcCtD
Plerixafor—Discomfort—Metformin—type 2 diabetes mellitus	0.000702	0.00129	CcSEcCtD
Plerixafor—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000701	0.00129	CcSEcCtD
Plerixafor—Nausea—Glipizide—type 2 diabetes mellitus	0.000699	0.00129	CcSEcCtD
Plerixafor—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000699	0.00129	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	0.000697	0.00216	CbGpPWpGaD
Plerixafor—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000696	0.00128	CcSEcCtD
Plerixafor—Pain—Gliclazide—type 2 diabetes mellitus	0.000696	0.00128	CcSEcCtD
Plerixafor—Constipation—Gliclazide—type 2 diabetes mellitus	0.000696	0.00128	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.000695	0.00215	CbGpPWpGaD
Plerixafor—Rash—Glimepiride—type 2 diabetes mellitus	0.000693	0.00128	CcSEcCtD
Plerixafor—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000692	0.00127	CcSEcCtD
Plerixafor—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000692	0.00127	CcSEcCtD
Plerixafor—Rash—Sitagliptin—type 2 diabetes mellitus	0.000691	0.00127	CcSEcCtD
Plerixafor—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00069	0.00127	CcSEcCtD
Plerixafor—Headache—Glimepiride—type 2 diabetes mellitus	0.000688	0.00127	CcSEcCtD
Plerixafor—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000687	0.00127	CcSEcCtD
Plerixafor—Headache—Sitagliptin—type 2 diabetes mellitus	0.000686	0.00126	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000681	0.00125	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	0.000681	0.00211	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ACACA—type 2 diabetes mellitus	0.000679	0.0021	CbGpPWpGaD
Plerixafor—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000678	0.00125	CcSEcCtD
Plerixafor—Insomnia—Valsartan—type 2 diabetes mellitus	0.000676	0.00125	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000673	0.00124	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.000671	0.00208	CbGpPWpGaD
Plerixafor—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000671	0.00124	CcSEcCtD
Plerixafor—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00067	0.00123	CcSEcCtD
Plerixafor—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00067	0.00123	CcSEcCtD
Plerixafor—Shock—Metformin—type 2 diabetes mellitus	0.00067	0.00123	CcSEcCtD
Plerixafor—Insomnia—Orlistat—type 2 diabetes mellitus	0.000668	0.00123	CcSEcCtD
Plerixafor—Malaise—Losartan—type 2 diabetes mellitus	0.000668	0.00123	CcSEcCtD
Plerixafor—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000668	0.00123	CcSEcCtD
Plerixafor—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000668	0.00123	CcSEcCtD
Plerixafor—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000666	0.00123	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000666	0.00123	CcSEcCtD
Plerixafor—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000665	0.00123	CcSEcCtD
Plerixafor—Syncope—Losartan—type 2 diabetes mellitus	0.000664	0.00122	CcSEcCtD
Plerixafor—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000663	0.00122	CcSEcCtD
Plerixafor—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000662	0.00122	CcSEcCtD
Plerixafor—Skin disorder—Metformin—type 2 diabetes mellitus	0.000661	0.00122	CcSEcCtD
Plerixafor—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000659	0.00121	CcSEcCtD
Plerixafor—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000658	0.00121	CcSEcCtD
Plerixafor—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000658	0.00121	CcSEcCtD
Plerixafor—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000655	0.00121	CcSEcCtD
Plerixafor—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000655	0.00121	CcSEcCtD
Plerixafor—Nausea—Glimepiride—type 2 diabetes mellitus	0.000653	0.0012	CcSEcCtD
Plerixafor—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000651	0.0012	CcSEcCtD
Plerixafor—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000651	0.0012	CcSEcCtD
Plerixafor—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00065	0.0012	CcSEcCtD
Plerixafor—Asthenia—Glyburide—type 2 diabetes mellitus	0.00065	0.0012	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	0.000647	0.00201	CbGpPWpGaD
Plerixafor—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000646	0.00119	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000645	0.00119	CcSEcCtD
Plerixafor—Fatigue—Valsartan—type 2 diabetes mellitus	0.000644	0.00119	CcSEcCtD
Plerixafor—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000643	0.00118	CcSEcCtD
Plerixafor—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000642	0.00118	CcSEcCtD
Plerixafor—Pruritus—Glyburide—type 2 diabetes mellitus	0.000641	0.00118	CcSEcCtD
Plerixafor—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000639	0.00118	CcSEcCtD
Plerixafor—Constipation—Valsartan—type 2 diabetes mellitus	0.000639	0.00118	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000638	0.00117	CcSEcCtD
Plerixafor—Fatigue—Orlistat—type 2 diabetes mellitus	0.000637	0.00117	CcSEcCtD
Plerixafor—Erythema—Ramipril—type 2 diabetes mellitus	0.000635	0.00117	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.000633	0.00196	CbGpPWpGaD
Plerixafor—Shock—Irbesartan—type 2 diabetes mellitus	0.000632	0.00116	CcSEcCtD
Plerixafor—Pain—Orlistat—type 2 diabetes mellitus	0.000632	0.00116	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000631	0.00196	CbGpPWpGaD
Plerixafor—Arthralgia—Losartan—type 2 diabetes mellitus	0.000631	0.00116	CcSEcCtD
Plerixafor—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00063	0.00116	CcSEcCtD
Plerixafor—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00063	0.00116	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000627	0.00194	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SLC5A2—type 2 diabetes mellitus	0.000626	0.00194	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—AKT1—type 2 diabetes mellitus	0.000625	0.00194	CbGpPWpGaD
Plerixafor—Rash—Bromocriptine—type 2 diabetes mellitus	0.000625	0.00115	CcSEcCtD
Plerixafor—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000624	0.00115	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.000624	0.00193	CbGpPWpGaD
Plerixafor—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000624	0.00115	CcSEcCtD
Plerixafor—Discomfort—Losartan—type 2 diabetes mellitus	0.000623	0.00115	CcSEcCtD
Plerixafor—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000621	0.00114	CcSEcCtD
Plerixafor—Headache—Bromocriptine—type 2 diabetes mellitus	0.000621	0.00114	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00062	0.00114	CcSEcCtD
Plerixafor—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00062	0.00114	CcSEcCtD
Plerixafor—Dry mouth—Losartan—type 2 diabetes mellitus	0.000617	0.00114	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.000614	0.0019	CbGpPWpGaD
Plerixafor—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000611	0.00113	CcSEcCtD
Plerixafor—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000611	0.00113	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.00061	0.00189	CbGpPWpGaD
Plerixafor—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000609	0.00112	CcSEcCtD
Plerixafor—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000607	0.00112	CcSEcCtD
Plerixafor—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000605	0.00111	CcSEcCtD
Plerixafor—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000604	0.00111	CcSEcCtD
Plerixafor—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000599	0.0011	CcSEcCtD
Plerixafor—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000599	0.0011	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.000598	0.00185	CbGpPWpGaD
Plerixafor—Shock—Losartan—type 2 diabetes mellitus	0.000595	0.0011	CcSEcCtD
Plerixafor—Urticaria—Valsartan—type 2 diabetes mellitus	0.000594	0.00109	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.000594	0.00184	CbGpPWpGaD
Plerixafor—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000593	0.00109	CcSEcCtD
Plerixafor—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000591	0.00109	CcSEcCtD
Plerixafor—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000589	0.00109	CcSEcCtD
Plerixafor—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000589	0.00108	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000589	0.00182	CbGpPWpGaD
Plerixafor—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000588	0.00108	CcSEcCtD
Plerixafor—Fatigue—Metformin—type 2 diabetes mellitus	0.000587	0.00108	CcSEcCtD
Plerixafor—Urticaria—Orlistat—type 2 diabetes mellitus	0.000587	0.00108	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000585	0.00108	CcSEcCtD
Plerixafor—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000584	0.00108	CcSEcCtD
Plerixafor—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000584	0.00108	CcSEcCtD
Plerixafor—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000584	0.00108	CcSEcCtD
Plerixafor—Constipation—Metformin—type 2 diabetes mellitus	0.000582	0.00107	CcSEcCtD
Plerixafor—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000577	0.00106	CcSEcCtD
Plerixafor—Vomiting—Glyburide—type 2 diabetes mellitus	0.000576	0.00106	CcSEcCtD
Plerixafor—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000576	0.00106	CcSEcCtD
Plerixafor—Malaise—Ramipril—type 2 diabetes mellitus	0.000573	0.00105	CcSEcCtD
Plerixafor—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000573	0.00105	CcSEcCtD
Plerixafor—Rash—Glyburide—type 2 diabetes mellitus	0.000571	0.00105	CcSEcCtD
Plerixafor—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000571	0.00105	CcSEcCtD
Plerixafor—Syncope—Ramipril—type 2 diabetes mellitus	0.00057	0.00105	CcSEcCtD
Plerixafor—CXCR4—Disease—PCK1—type 2 diabetes mellitus	0.000569	0.00176	CbGpPWpGaD
Plerixafor—Headache—Glyburide—type 2 diabetes mellitus	0.000568	0.00105	CcSEcCtD
Plerixafor—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000565	0.00104	CcSEcCtD
Plerixafor—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000561	0.00103	CcSEcCtD
Plerixafor—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000558	0.00103	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000558	0.00173	CbGpPWpGaD
Plerixafor—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000557	0.00103	CcSEcCtD
Plerixafor—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000557	0.00103	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000555	0.00102	CcSEcCtD
Plerixafor—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000554	0.00102	CcSEcCtD
Plerixafor—CXCR4—Disease—TLE4—type 2 diabetes mellitus	0.000553	0.00171	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000551	0.00101	CcSEcCtD
Plerixafor—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000551	0.00101	CcSEcCtD
Plerixafor—Pain—Irbesartan—type 2 diabetes mellitus	0.000549	0.00101	CcSEcCtD
Plerixafor—Constipation—Irbesartan—type 2 diabetes mellitus	0.000549	0.00101	CcSEcCtD
Plerixafor—Insomnia—Losartan—type 2 diabetes mellitus	0.000547	0.00101	CcSEcCtD
Plerixafor—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000544	0.001	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000543	0.00168	CbGpPWpGaD
Plerixafor—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000543	0.001	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000541	0.00168	CbGpPWpGaD
Plerixafor—Urticaria—Metformin—type 2 diabetes mellitus	0.000541	0.000996	CcSEcCtD
Plerixafor—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000541	0.000996	CcSEcCtD
Plerixafor—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000539	0.000993	CcSEcCtD
Plerixafor—Nausea—Glyburide—type 2 diabetes mellitus	0.000538	0.000991	CcSEcCtD
Plerixafor—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000538	0.000991	CcSEcCtD
Plerixafor—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000538	0.000991	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000537	0.000989	CcSEcCtD
Plerixafor—Asthenia—Valsartan—type 2 diabetes mellitus	0.000536	0.000988	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000535	0.00166	CbGpPWpGaD
Plerixafor—Discomfort—Ramipril—type 2 diabetes mellitus	0.000534	0.000984	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.000533	0.00165	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HK1—type 2 diabetes mellitus	0.000532	0.00165	CbGpPWpGaD
Plerixafor—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000532	0.00098	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000531	0.00164	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.00053	0.00164	CbGpPWpGaD
Plerixafor—Asthenia—Orlistat—type 2 diabetes mellitus	0.00053	0.000976	CcSEcCtD
Plerixafor—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000529	0.000975	CcSEcCtD
Plerixafor—Pruritus—Valsartan—type 2 diabetes mellitus	0.000529	0.000974	CcSEcCtD
Plerixafor—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000529	0.000974	CcSEcCtD
Plerixafor—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000525	0.000967	CcSEcCtD
Plerixafor—Pruritus—Orlistat—type 2 diabetes mellitus	0.000523	0.000962	CcSEcCtD
Plerixafor—Fatigue—Losartan—type 2 diabetes mellitus	0.000521	0.00096	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000519	0.00161	CbGpPWpGaD
Plerixafor—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000518	0.000955	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000517	0.0016	CbGpPWpGaD
Plerixafor—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000517	0.000953	CcSEcCtD
Plerixafor—Pain—Losartan—type 2 diabetes mellitus	0.000517	0.000952	CcSEcCtD
Plerixafor—Constipation—Losartan—type 2 diabetes mellitus	0.000517	0.000952	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000515	0.0016	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GCKR—type 2 diabetes mellitus	0.000514	0.00159	CbGpPWpGaD
Plerixafor—Rash—Gliclazide—type 2 diabetes mellitus	0.000513	0.000945	CcSEcCtD
Plerixafor—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000513	0.000944	CcSEcCtD
Plerixafor—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000511	0.000942	CcSEcCtD
Plerixafor—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00051	0.00094	CcSEcCtD
Plerixafor—Shock—Ramipril—type 2 diabetes mellitus	0.00051	0.000939	CcSEcCtD
Plerixafor—Headache—Gliclazide—type 2 diabetes mellitus	0.00051	0.000939	CcSEcCtD
Plerixafor—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000508	0.000936	CcSEcCtD
Plerixafor—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000508	0.000935	CcSEcCtD
Plerixafor—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000505	0.000931	CcSEcCtD
Plerixafor—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000504	0.000927	CcSEcCtD
Plerixafor—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000501	0.000923	CcSEcCtD
Plerixafor—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000498	0.000918	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000498	0.00154	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000498	0.00154	CbGpPWpGaD
Plerixafor—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000494	0.00091	CcSEcCtD
Plerixafor—Dizziness—Valsartan—type 2 diabetes mellitus	0.000494	0.00091	CcSEcCtD
Plerixafor—CXCR4—Disease—ALDOB—type 2 diabetes mellitus	0.000493	0.00153	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000493	0.00153	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000493	0.00153	CbGpPWpGaD
Plerixafor—Dizziness—Orlistat—type 2 diabetes mellitus	0.000488	0.0009	CcSEcCtD
Plerixafor—Asthenia—Metformin—type 2 diabetes mellitus	0.000488	0.000899	CcSEcCtD
Plerixafor—Nausea—Gliclazide—type 2 diabetes mellitus	0.000483	0.00089	CcSEcCtD
Plerixafor—Pruritus—Metformin—type 2 diabetes mellitus	0.000482	0.000887	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000481	0.00149	CbGpPWpGaD
Plerixafor—Urticaria—Losartan—type 2 diabetes mellitus	0.00048	0.000885	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000478	0.00148	CbGpPWpGaD
Plerixafor—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000478	0.00088	CcSEcCtD
Plerixafor—Vomiting—Valsartan—type 2 diabetes mellitus	0.000475	0.000875	CcSEcCtD
Plerixafor—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000473	0.000872	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000472	0.00087	CcSEcCtD
Plerixafor—Rash—Valsartan—type 2 diabetes mellitus	0.000471	0.000868	CcSEcCtD
Plerixafor—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000471	0.000867	CcSEcCtD
Plerixafor—CXCR4—Disease—SPRY2—type 2 diabetes mellitus	0.00047	0.00146	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.00047	0.00146	CbGpPWpGaD
Plerixafor—Vomiting—Orlistat—type 2 diabetes mellitus	0.00047	0.000865	CcSEcCtD
Plerixafor—Insomnia—Ramipril—type 2 diabetes mellitus	0.000469	0.000864	CcSEcCtD
Plerixafor—Headache—Valsartan—type 2 diabetes mellitus	0.000468	0.000862	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000467	0.00145	CbGpPWpGaD
Plerixafor—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000466	0.000858	CcSEcCtD
Plerixafor—Rash—Orlistat—type 2 diabetes mellitus	0.000466	0.000858	CcSEcCtD
Plerixafor—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000465	0.000857	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000465	0.00144	CbGpPWpGaD
Plerixafor—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000465	0.000857	CcSEcCtD
Plerixafor—Headache—Orlistat—type 2 diabetes mellitus	0.000463	0.000852	CcSEcCtD
Plerixafor—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000462	0.000851	CcSEcCtD
Plerixafor—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000461	0.000849	CcSEcCtD
Plerixafor—CXCR4—Disease—RBP4—type 2 diabetes mellitus	0.000458	0.00142	CbGpPWpGaD
Plerixafor—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000456	0.00084	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000456	0.00141	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000455	0.00141	CbGpPWpGaD
Plerixafor—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000455	0.000837	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000453	0.00141	CbGpPWpGaD
Plerixafor—Dizziness—Metformin—type 2 diabetes mellitus	0.00045	0.000829	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000448	0.00139	CbGpPWpGaD
Plerixafor—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000448	0.000824	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000447	0.00139	CbGpPWpGaD
Plerixafor—Fatigue—Ramipril—type 2 diabetes mellitus	0.000447	0.000823	CcSEcCtD
Plerixafor—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000445	0.00082	CcSEcCtD
Plerixafor—Nausea—Valsartan—type 2 diabetes mellitus	0.000444	0.000818	CcSEcCtD
Plerixafor—Constipation—Ramipril—type 2 diabetes mellitus	0.000443	0.000816	CcSEcCtD
Plerixafor—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00044	0.000809	CcSEcCtD
Plerixafor—Nausea—Orlistat—type 2 diabetes mellitus	0.000439	0.000808	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000439	0.00136	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000434	0.00135	CbGpPWpGaD
Plerixafor—Asthenia—Losartan—type 2 diabetes mellitus	0.000434	0.000799	CcSEcCtD
Plerixafor—Vomiting—Metformin—type 2 diabetes mellitus	0.000433	0.000797	CcSEcCtD
Plerixafor—Rash—Metformin—type 2 diabetes mellitus	0.000429	0.00079	CcSEcCtD
Plerixafor—Dermatitis—Metformin—type 2 diabetes mellitus	0.000429	0.00079	CcSEcCtD
Plerixafor—CXCR4—Disease—SLC2A2—type 2 diabetes mellitus	0.000428	0.00133	CbGpPWpGaD
Plerixafor—Pruritus—Losartan—type 2 diabetes mellitus	0.000428	0.000788	CcSEcCtD
Plerixafor—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000427	0.000787	CcSEcCtD
Plerixafor—Headache—Metformin—type 2 diabetes mellitus	0.000426	0.000785	CcSEcCtD
Plerixafor—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000425	0.000782	CcSEcCtD
Plerixafor—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000424	0.000781	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000423	0.00131	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MTR—type 2 diabetes mellitus	0.000419	0.0013	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000417	0.00129	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000415	0.00129	CbGpPWpGaD
Plerixafor—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000414	0.000762	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000414	0.00128	CbGpPWpGaD
Plerixafor—Urticaria—Ramipril—type 2 diabetes mellitus	0.000412	0.000758	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000412	0.00128	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NAMPT—type 2 diabetes mellitus	0.000411	0.00127	CbGpPWpGaD
Plerixafor—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00041	0.000755	CcSEcCtD
Plerixafor—CXCR4—Disease—GCK—type 2 diabetes mellitus	0.000409	0.00127	CbGpPWpGaD
Plerixafor—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000408	0.000752	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000408	0.00126	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000407	0.00126	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IAPP—type 2 diabetes mellitus	0.000406	0.00126	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000406	0.00126	CbGpPWpGaD
Plerixafor—Rash—Irbesartan—type 2 diabetes mellitus	0.000405	0.000746	CcSEcCtD
Plerixafor—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000405	0.000745	CcSEcCtD
Plerixafor—Nausea—Metformin—type 2 diabetes mellitus	0.000404	0.000745	CcSEcCtD
Plerixafor—Headache—Irbesartan—type 2 diabetes mellitus	0.000402	0.000741	CcSEcCtD
Plerixafor—Dizziness—Losartan—type 2 diabetes mellitus	0.0004	0.000736	CcSEcCtD
Plerixafor—CXCR4—Disease—SLC9A1—type 2 diabetes mellitus	0.000399	0.00124	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000398	0.00123	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000387	0.0012	CbGpPWpGaD
Plerixafor—Vomiting—Losartan—type 2 diabetes mellitus	0.000384	0.000708	CcSEcCtD
Plerixafor—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000382	0.000703	CcSEcCtD
Plerixafor—Nausea—Irbesartan—type 2 diabetes mellitus	0.000382	0.000703	CcSEcCtD
Plerixafor—Rash—Losartan—type 2 diabetes mellitus	0.000381	0.000702	CcSEcCtD
Plerixafor—Dermatitis—Losartan—type 2 diabetes mellitus	0.000381	0.000701	CcSEcCtD
Plerixafor—Headache—Losartan—type 2 diabetes mellitus	0.000379	0.000698	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000377	0.00117	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HMGA1—type 2 diabetes mellitus	0.000374	0.00116	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000373	0.00116	CbGpPWpGaD
Plerixafor—Asthenia—Ramipril—type 2 diabetes mellitus	0.000372	0.000685	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000371	0.00115	CbGpPWpGaD
Plerixafor—Pruritus—Ramipril—type 2 diabetes mellitus	0.000367	0.000675	CcSEcCtD
Plerixafor—CXCR4—Disease—PSMD6—type 2 diabetes mellitus	0.000366	0.00114	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SNAP25—type 2 diabetes mellitus	0.000366	0.00114	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.00036	0.00112	CbGpPWpGaD
Plerixafor—Nausea—Losartan—type 2 diabetes mellitus	0.000359	0.000661	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000357	0.00111	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CYBA—type 2 diabetes mellitus	0.000355	0.0011	CbGpPWpGaD
Plerixafor—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000355	0.000653	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000353	0.00109	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CALCA—type 2 diabetes mellitus	0.000343	0.00106	CbGpPWpGaD
Plerixafor—Dizziness—Ramipril—type 2 diabetes mellitus	0.000343	0.000631	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000335	0.00104	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000332	0.00103	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SLC2A1—type 2 diabetes mellitus	0.000331	0.00103	CbGpPWpGaD
Plerixafor—Vomiting—Ramipril—type 2 diabetes mellitus	0.00033	0.000607	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000329	0.00102	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000329	0.00102	CbGpPWpGaD
Plerixafor—Rash—Ramipril—type 2 diabetes mellitus	0.000327	0.000602	CcSEcCtD
Plerixafor—CXCR4—Disease—NOS1—type 2 diabetes mellitus	0.000327	0.00101	CbGpPWpGaD
Plerixafor—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000327	0.000601	CcSEcCtD
Plerixafor—Headache—Ramipril—type 2 diabetes mellitus	0.000325	0.000598	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000325	0.00101	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TCF7L2—type 2 diabetes mellitus	0.000323	0.001	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000321	0.000995	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000321	0.000995	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.00032	0.000993	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.00032	0.000993	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000319	0.000988	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SLC2A4—type 2 diabetes mellitus	0.000318	0.000985	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000316	0.000979	CbGpPWpGaD
Plerixafor—Nausea—Ramipril—type 2 diabetes mellitus	0.000308	0.000567	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000305	0.000944	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.0003	0.00093	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000293	0.000908	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000289	0.000897	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000286	0.000887	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000284	0.000881	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000283	0.000876	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000278	0.000863	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000278	0.000861	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000277	0.00086	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TGFBR2—type 2 diabetes mellitus	0.000276	0.000857	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000276	0.000856	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000272	0.000844	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CDKN2B—type 2 diabetes mellitus	0.000268	0.00083	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000266	0.000825	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000264	0.000819	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOB—type 2 diabetes mellitus	0.000261	0.000809	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000257	0.000798	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000257	0.000796	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000257	0.000796	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000253	0.000784	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.00025	0.000774	CbGpPWpGaD
Plerixafor—CXCR4—Disease—LPL—type 2 diabetes mellitus	0.000249	0.000773	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000249	0.000771	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000249	0.00077	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000244	0.000757	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ADCY5—type 2 diabetes mellitus	0.000244	0.000757	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000243	0.000754	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000243	0.000754	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.00024	0.000745	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PPP2CA—type 2 diabetes mellitus	0.000234	0.000725	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000234	0.000724	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CCR5—type 2 diabetes mellitus	0.00023	0.000712	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000226	0.000702	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000225	0.000698	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MTHFR—type 2 diabetes mellitus	0.000224	0.000696	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000222	0.00069	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000222	0.00069	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000219	0.000679	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000218	0.000676	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HIF1A—type 2 diabetes mellitus	0.000214	0.000664	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IRS2—type 2 diabetes mellitus	0.000214	0.000662	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CALM1—type 2 diabetes mellitus	0.00021	0.00065	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOE—type 2 diabetes mellitus	0.000209	0.000648	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000208	0.000646	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOA1—type 2 diabetes mellitus	0.000207	0.00064	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000205	0.000634	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000204	0.000634	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS2—type 2 diabetes mellitus	0.000195	0.000604	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000194	0.0006	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000192	0.000594	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000189	0.000586	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000189	0.000586	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000188	0.000584	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000188	0.000581	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IRS1—type 2 diabetes mellitus	0.000186	0.000578	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000186	0.000575	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000183	0.000567	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000182	0.000565	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.00018	0.000558	CbGpPWpGaD
Plerixafor—CXCR4—Disease—INS—type 2 diabetes mellitus	0.000179	0.000553	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000175	0.000541	CbGpPWpGaD
Plerixafor—CXCR4—Disease—AKT2—type 2 diabetes mellitus	0.000173	0.000535	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000171	0.00053	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SERPINE1—type 2 diabetes mellitus	0.000164	0.000508	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000164	0.000508	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000161	0.000499	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—C3—type 2 diabetes mellitus	0.000157	0.000487	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS3—type 2 diabetes mellitus	0.000157	0.000485	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PIK3R1—type 2 diabetes mellitus	0.000157	0.000485	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.00015	0.000465	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.00015	0.000464	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000149	0.000463	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000147	0.000455	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000146	0.000454	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000146	0.000454	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000145	0.000448	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PTGS2—type 2 diabetes mellitus	0.000143	0.000444	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000138	0.000428	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000131	0.000405	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—INS—type 2 diabetes mellitus	0.000125	0.000388	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000123	0.000381	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000121	0.000375	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000121	0.000375	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.00012	0.000373	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SRC—type 2 diabetes mellitus	0.000116	0.000359	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000115	0.000356	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.00011	0.00034	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.00011	0.00034	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TGFB1—type 2 diabetes mellitus	0.000104	0.000321	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000103	0.00032	CbGpPWpGaD
Plerixafor—CXCR4—Disease—EGFR—type 2 diabetes mellitus	0.000102	0.000315	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.39e-05	0.000291	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.31e-05	0.000289	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.25e-05	0.000287	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.8e-05	0.000273	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.7e-05	0.00027	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.53e-05	0.000264	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SRC—type 2 diabetes mellitus	8.11e-05	0.000251	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.9e-05	0.000245	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6—type 2 diabetes mellitus	7.8e-05	0.000242	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.25e-05	0.000225	CbGpPWpGaD
Plerixafor—CXCR4—Disease—AKT1—type 2 diabetes mellitus	7.2e-05	0.000223	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.11e-05	0.00022	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6—type 2 diabetes mellitus	5.46e-05	0.000169	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.04e-05	0.000156	CbGpPWpGaD
